Photocure ASA - Annual General Meeting in Photocure ASA

Published: 28 April 2011Medical congresses & eventsFinancial Investment & Stock

Oslo, Norway, April 28, 2011.

The Annual General Meeting in Photocure ASA took place on April 27, 2011.

Please find attached minutes from the meeting.

For further information, please contact:

President and CEO Kjetil Hestdal
E-mail: kh@photocure.no
Mobile: +47 913 19 535

CFO Christian Fekete
E-mail: cf@photocure.no
Mobile: +47 916 42 938

www.photocure.com

This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

News and events

New study publication reinforces the clinical benefits of Blue Light Cystoscopy in the ASC setting; supports ongoing initiatives to further improve reimbursement

Oslo, Norway

3 January 2023

NEWS POST

Bladder Cancer: New Meta-analysis

Oslo, Norway

15 December 2022

NEWS POST

Photocure Partner Asieris announces First Patient treated in Hexvix Real-world Evidence study in Hainan, China

Oslo, Norway

12 December 2022

NEWS POST

Photocure to participate in the NALSC and DNB Healthcare Conferences in December

Oslo, Norway

5 December 2022

PRESS-RELEASE

New Evidence: Positive Impact of Blue Light Cystoscopy on Recurrence in Bladder Cancer Presented at the Annual SUO Meeting

Oslo, Norway

5 December 2022

OSE Notice

Photocure: CMS improves Medicare reimbursement for Blue Light Cystoscopy with Cysview and expands access in the surveillance setting

Oslo, Norway

7 November 2022

PRESS-RELEASE

Photocure Partner Asieris announces 1[st] Patient enrolled in Hexvix Phase III trial in China

Oslo, Norway

4 November 2022

OSE Notice

Photocure ASA: Results for the third quarter of 2022

Oslo, Norway

2 November 2022

OSE Notice

Photocure ASA: Invitation to presentation of third quarter 2022 financial results

Oslo, Norway

25 October 2022

PRESS-RELEASE

Data presented at the International Bladder Cancer Network (IBCN) meeting demonstrate a reduction in the risk of recurrence with the use of BLC

Oslo, Norway

4 October 2022

PRESS-RELEASE

Photocure Announces the Commercial Availability of Karl Storz’s New Blue Light System in the U.S.

Oslo, Norway

28 September 2022

PRESS-RELEASE

New study demonstrates that tumor removal in the outpatient setting is as good as TURBT under general anesthesia

Oslo, Norway

20 September 2022

PRESS-RELEASE

Photocure Partner Asieris announces coverage of Hexvix by the Lecheng Global Specialty Drug Insurance

Oslo, Norway

15 September 2022

PRESS-RELEASE

Bladder Cancer technology: New KARL STORZ Blue Light Cystoscopy system featured during E-Masterclass in Urology

Oslo, Norway

8 September 2022

Photocure ASA - Annual General Meeting in Photocure ASA

News and events

E-mail: info@photocure.no

E-mail: info@photocure.com

E-mail: kontakt@photocure.com